B. Lynne Parshall, Director at IONIS PHARMACEUTICALS INC (IONS), sold 5,000 shares at $41.87 ($210K) on 2025-08-06, disclosed to the SEC on 2025-08-08.
Scheduled sale ($210k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.87 | 4,600 | $193K | 91.9% |
| 2 | $42.63 | 400 | $17K | 8.1% |
| Total | $41.93 avg | 5,000 | $210K | 100% |
| Filing → |
| IONS | SELL | 2026-04-17 | $381K | — | Filing → |
| CYTK | SELL | 2026-03-02 | $306K | — | Filing → |
| IONS | SELL | 2026-02-13 | $414K | — | Filing → |